Screener
Allogene Therapeutics ALLO Business Segments — Operating Expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Allogene Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: Allogene Therapeutics’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-034585
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| All other development costs | 1,999 | 10,390 |
| Payroll | 14,444 | 19,601 |
| Facilities & IT-related spend | 6,418 | 7,319 |
| Supporting external spend | 4,372 | 5,846 |
| Other operating expenses | 11,190 | 15,813 |
| Total operating expenses | 46,092 | 65,191 |
| Other income (expenses), net | 3,485 | 5,458 |
| Net loss | (42,607) | (59,733) |
Item 1. Financial Statements - Unaudited
FAQ
- What is Allogene Therapeutics's business segments — operating expenses?
- Allogene Therapeutics (ALLO) reported business segments — operating expenses of $46.09M in Q1 2026.
- How has Allogene Therapeutics's business segments — operating expenses changed year-over-year?
- Allogene Therapeutics's business segments — operating expenses decreased by 29.3% year-over-year, from $65.19M to $46.09M.
- What is the long-term trend for Allogene Therapeutics's business segments — operating expenses?
- Over 2 years (2023 to 2025), Allogene Therapeutics's business segments — operating expenses has grown at a -20.1% compound annual growth rate (CAGR), from $327.83M to $209.32M.
- What does business segments — operating expenses mean?
- This metric represents the total cash and non-cash costs incurred to operate the business segment during the reporting period. It is a primary indicator of the company's burn rate and overall operational scale. Investors use this to evaluate the company's ability to manage its financial resources while advancing its clinical pipeline.
Ask your AI about Allogene Therapeutics's business segments — operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude